Fair Value Measurements and Hierarchy - Summary of Changes in Fair Value (Details) - P3 Health Partners Inc. - USD ($) |
1 Months Ended | 2 Months Ended | 3 Months Ended | 6 Months Ended | 9 Months Ended | 11 Months Ended | 12 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 |
Dec. 02, 2021 |
Dec. 31, 2021 |
Nov. 30, 2021 |
Jun. 30, 2022 |
Jun. 30, 2021 |
Mar. 31, 2021 |
Jun. 30, 2022 |
Jun. 30, 2021 |
Sep. 30, 2021 |
Dec. 02, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||||||||||
| Financial Designation, Predecessor and Successor [Fixed List] | Successor | Successor | Successor | Predecessor | Predecessor | Successor | Predecessor | Predecessor | Predecessor | Predecessor | |||
| Beginning balance | $ 6,316,605 | $ 502,276 | $ 6,316,605 | $ 6,316,605 | $ 6,316,605 | ||||||||
| Mark-to-Market Adjustment for Stock Warrants | $ (344,101) | 10,661,579 | |||||||||||
| Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] | Mark-to-Market Adjustment of Stock Warrants | Mark-to-Market Adjustment of Stock Warrants | Mark-to-Market Adjustment of Stock Warrants | Mark To Market Adjustment Of Foresight Stock Warrants | Mark-to-Market Adjustment of Stock Warrants | Mark-to-Market Adjustment of Stock Warrants | |||||||
| Ending balance | $ 502,276 | $ 502,276 | $ 158,175 | $ 16,978,184 | $ 158,175 | $ 16,978,184 | $ 6,316,605 | ||||||
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Indicates line item in statement in which net income is reported that includes gain (loss) from liability measured at fair value using unobservable input (level 3). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Indicates designation of financial information when substantially all business or separately identifiable line of business transfers from one entity to another entity. Acceptable values are "Predecessor" and "Successor". Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|